Clock.bio: New biotech startup aims to extend human healthspan by 20 years
Endpoints News - 31-Aug-2024Revolutionary approach to reverse ageing process with CRISPR gene editing technology
Mark Kotter
Neurosurgeon, stem cell biologist and founder of bit.bio
Mark Kotter is a stem cell biologist and neurosurgeon at the University of Cambridge. Kotter is the founder and CEO of bit.bio, co-founder of the cultured meat startup Meatable and Myelopathy.org, a charity dedicated to common form of spinal cord injury. Focused on transitioning biology to engineering to address cancer and the consequences of poor health due to ageing.
Visit website: http://www.neuroscience.cam.ac.uk/directory/profile.php?=mrk25
See also
Details last updated 12-Apr-2021
Mark Kotter News
Bit.bio reveals early pipeline of regenerative medicine candidates
Endpoints News - 08-Nov-2023Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025
Synthetic human cells revolution: bit.bio achieves mass production breakthrough
iNews - 15-Jun-2023Paves way for potential medical research, organ manufacturing and disease treatment advances
Bit Bio secures $41.5 M funding to produce human cells
Biospace - 15-Jun-2020UK-based startup reprogramming stem cells to generate new cell therapies
Mark Kotter is also referenced in the following:
Global Healthspan Summit (GHS) 2025
04-Feb-2025
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Longevity Salon: The Skin Frontier — Measure. Repair. Reverse.
12-Nov-2025
Event organised by London Longevity and sponsored by Mitra Bio, a leading skin epigenetics company (London, UK)
Rejuvenation with stem cells
Beyond Biotech podcast - Mark Kotter discusses how stem cells can be used for rejuvenation
Stem cells, lab-grown meat, and potential new medical treatments, with Mark Kotter
Mark Kotter discusses stem cells, cultivated meat, and emerging medical treatments
